Skip to content

Public FDA record

Z-0970-2018: Immunoassay Premium Plus Controls (3x4x5mL and 12x5mL packages)

Recall record Z-0970-2018 for Randox Laboratories. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0970-2018
Company in FDA record
Randox Laboratories
FDA record creation date
Mar 12, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class III

Reason stated in the source

The ACTH in Immunoassay Premium and Premium Plus quality control does not meet the quoted reconstituted stability claim in the product IFU.

Source facts

Action
On July 24, 2017 an Urgent notice was issued instructing customers to place a copy a notice in all kits remaining in stock. This notifies customers that they should amend the claims for open stability in the instructions for use, to state use immediately after the 30 minute reconstitution period. Questions or concerns can be emailed to technical.services@randox.com
Initiated
2017-08-11
Root cause
Device Design
Terminated
2019-03-29
Distribution
Distribution US nationwide.
Recall number
Z-0970-2018
Recall status
Terminated
CDRH record ID
161283
FDA record created
2018-03-12
Recall event number
79076

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗